← Back to Search

Contextual PGD for Pain Management in Older Adults

N/A
Waitlist Available
Led By Jorie Butler, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Eligible VHA patients who are age 65 and older with a diagnosis of chronic pain defined by ICD 10 codes
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between 2 years and 4.5 years after study start
Awards & highlights
No Placebo-Only Group

Summary

This trial is focused on understanding how contextual patient generated data (PGD) affects Veteran patients 65 and older with chronic pain.

Who is the study for?
This trial is for Veterans aged 65 or older with chronic pain, their informal caregivers, and clinicians involved in their care. Participants must be within the Salt Lake City area. It's not suitable for Veterans who require a legal representative to consent.
What is being tested?
The study tests how sharing contextual patient-generated data (like daily routines and support levels) affects satisfaction with care plans and adherence among elderly patients with chronic pain when this information is available during medical visits.
What are the potential side effects?
Since this trial involves collecting and using data rather than medication, traditional side effects are not applicable. However, there may be privacy concerns or emotional impacts from discussing personal contexts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 or older with chronic pain diagnosed by a doctor.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between 2 years and 4.5 years after study start
This trial's timeline: 3 weeks for screening, Varies for treatment, and between 2 years and 4.5 years after study start for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence to the Pain Care Plan
Secondary study objectives
Pain Function
Patient Satisfaction with the Visit
Patient perspective of Shared Decision Making
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
This group will contribute PGHD and it will be available in the study visit.
Group II: ControlActive Control1 Intervention
This group may contribute PGHD but if so, it will not be available during a study visit, it will be available to the provider in a subsequent visit.

Find a Location

Who is running the clinical trial?

University of UtahOTHER
1,146 Previous Clinical Trials
1,698,794 Total Patients Enrolled
25 Trials studying Pain
177,414 Patients Enrolled for Pain
VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,436 Total Patients Enrolled
22 Trials studying Pain
5,155 Patients Enrolled for Pain
Jorie Butler, PhDPrincipal InvestigatorVA Salt Lake City Health Care System, Salt Lake City, UT

Media Library

Experimental Clinical Trial Eligibility Overview. Trial Name: NCT04560920 — N/A
Pain Research Study Groups: Experimental, Control
Pain Clinical Trial 2023: Experimental Highlights & Side Effects. Trial Name: NCT04560920 — N/A
Experimental 2023 Treatment Timeline for Medical Study. Trial Name: NCT04560920 — N/A
~67 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top